Baystreet Staff - Wednesday, October 4, 2006 Ondine Biopharma Corp. 12:05 PM EST - Ondine Biopharma Corp. : said a clinical trial of its Periowave product showed "significant improvement" in treating periodontal disease. Ondine Biopharma Corp. T.OBP are trading up 3 cents at $1.80.